From July 1, 2023 to September 30, 2023, the company has repurchased 29,046 shares, representing 0.2% for $0.77 million. With this, the company has completed the repurchase of 188,029 shares, representing 1.28% for $5 million under the buyback announced on April 13, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
25.54 USD | +1.11% | -7.43% | +12.71% |
08/05 | Transcript : Anika Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q1 EPS $0.09 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.71% | 370M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-13.95% | 32.43B | |
+55.89% | 24.28B | |
-16.01% | 15.52B | |
-41.29% | 12.17B | |
-15.41% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |
- Stock Market
- Equities
- ANIK Stock
- News Anika Therapeutics, Inc.
- Tranche Update on Anika Therapeutics, Inc.'s Equity Buyback Plan announced on April 13, 2023.